[1]Wilkinson DM, Huberman BA.A method forfinding communities of related genes[J].Proc Natl Acad Sci U S A, 2004, 101 (Suppl 1) :5241-5248.
|
[2]Holme P, Huss M, Jeong H.Subnetwork hierarchies of biochemical pathways[J].Bioinformatics, 2003, 19 (4) :532-538.
|
[3]Sakata S, Yamamori T.Topological relationships between brain and social networks[J].Neural Networks, 2007, 20 (1) :12-21.
|
[4]Bodin?, Crona B, Ernstson H.Social networks in natural resource management:what is there to learn from a structural perspective[J].Ecology and Society, 2006, 11 (2) :r2.
|
[5]Palla G, Derényi I, Farkas I, et al.Uncovering the overlapping community structure of complex networks in nature and society[J].Nature, 2005, 435 (7043) :814-818.
|
[6]中华肝脏病学会脂肪肝和酒精性肝病学组.非酒精性脂肪肝诊断标准[J].肝脏, 2002, 7 (4) :附页2.
|
[7]刘军.整体网分析讲义[M].上海:格致出版社, 2009:97-103.
|
[8]罗家德.社会网分析讲义 (第二版) [M].北京:社会科学文献出版社, 2010:188-189, 191-194.
|
[9]Clauset A, Newman ME, Moore C.Finding community structure in very large networks[J].Phys Rev E Stat Nonlin Soft Matter Phys, 2004, 70 (6 Pt 2) :066111.
|
[10]Newman ME, Girvan M.Finding and evaluating community structure in networks[J].Phys Rev E Stat Nonlin Soft Matter Phys, 2004, 69 (2 Pt 2) :026113.
|
[11]Girvan M, Newman ME.Community structure in social and biological networks[J].Proc Natl Acad Sci U S A, 2002, 99 (12) :7821-7826.
|
[1] | Junting SAI, Xiuhui LI. Research advances in traditional Chinese medicine syndromes of fatty liver disease[J]. Journal of Clinical Hepatology, 2024, 40(10): 1929-1932. doi: 10.12449/JCH241001 |
[2] | Chong CHEN, Ying LYU, Xilei CHEN, Chenghai LIU, Ping LIU, Yongping MU. Effect of endoscopic ligation combined with traditional Chinese medicine syndrome differentiation-based treatment in the secondary prevention of esophageal variceal bleeding in patients with liver cirrhosis[J]. Journal of Clinical Hepatology, 2022, 38(5): 1075-1080. doi: 10.3969/j.issn.1001-5256.2022.05.019 |
[3] | Jiang DENG, Zhiyi HAN, Cailan XIAO, Yating SUN, Yajun JI, Li AO, Yonghong ZHANG, Xiaolan LU. Prevalence rate of non-obese fatty liver disease and related influencing factors[J]. Journal of Clinical Hepatology, 2021, 37(11): 2600-2604. doi: 10.3969/j.issn.1001-5256.2021.11.022 |
[4] | Chen KeDi, Yang DaoFeng, Chen Guang. Clinical features and diagnosis and treatment of acute fatty liver of pregnancy: a report of 12 cases[J]. Journal of Clinical Hepatology, 2018, 34(3): 558-561. doi: 10.3969/j.issn.1001-5256.2018.03.022 |
[5] | Huang YingTing, Dai Biao. Association between fatty liver disease and lacunar infarction[J]. Journal of Clinical Hepatology, 2018, 34(12): 2619-2623. doi: 10.3969/j.issn.1001-5256.2018.12.022 |
[6] | Li XiuChi, Ruan GaiQing, LYU JiaEn, Sun MoQian, Wang MingMing. A preliminary investigation and feature analysis of non-alcoholic fatty liver and nonalcoholic steatohepatitis in employees in an IT company[J]. Journal of Clinical Hepatology, 2017, 33(7): 1324-1327. doi: 10.3969/j.issn.1001-5256.2017.07.024 |
[7] | Meng YuLin, Zhang HaiYan, Song BaoGuo, Zhou HuiLan, Jin XiuPing, Shi GuoHui. An investigation of the prevalence rate of fatty liver disease among people undergoing physical examination in Tangshan, China[J]. Journal of Clinical Hepatology, 2017, 33(12): 2376-2380. doi: 10.3969/j.issn.1001-5256.2017.12.024 |
[8] | He Jia, Li Wei, Li Kuan, Ning HuiBin, Liu JunPing, Mao ZhongShan, Shang Jia. Clinical features of chronic HBV/HCV infection complicated by mild hepatic steatosis[J]. Journal of Clinical Hepatology, 2016, 32(9): 1717-1720. doi: 10.3969/j.issn.1001-5256.2016.09.016 |
[9] | Li JingYing, Li XiuHui, Zhang Yin, Gou ChunYan, Li Li. Syndrome differentiation-based treatment of primary liver cancer developed by Professor Qian Ying: an analysis of experience[J]. Journal of Clinical Hepatology, 2016, 32(7): 1342-1344. doi: 10.3969/j.issn.1001-5256.2016.07.026 |
[10] | Zhang Yu, Cheng Jun. Hepatitis C virus related fatty liver[J]. Journal of Clinical Hepatology, 2015, 31(7): 1034-1037. doi: 10.3969/j.issn.1001-5256.2015.07.009 |
[11] | Pang XueQin, Chen WeiChang, Feng Huang, Tian WenYan. Risk factors for non- alcoholic fatty liver disease: a multivariate analysis[J]. Journal of Clinical Hepatology, 2014, 30(9): 903-905. doi: 10.3969/j.issn.1001-5256.2014.09.016 |
[12] | Huang ZhiPeng, Su ZhiJun, Jiang JianJia, Sun BingQing, Lin ZhenZhong, Ceng ZhiXiong. Correlation of severity of non-alcoholic fatty liver disease with visceral adipose tissue area, body mass index, and waist circumference[J]. Journal of Clinical Hepatology, 2013, 29(6): 445-448. |
[13] | Li Lei, Ding HuiGuo. Clinical features of cirrhosis due to nonalcoholic steatohepatitis[J]. Journal of Clinical Hepatology, 2011, 27(10): 1032-1035. |
[14] | Xiang GuoQing, Meng XiaoDan, Wang BingYuan. Prevalence of fatty liver among people with different occupation in Shenyang[J]. Journal of Clinical Hepatology, 2010, 26(3): 283-285. |
[15] | Qin YongJun, Sun JieSheng, Wang BingYuan, Liu PengLiang, Sun FuRong, Liu CuiXiang, Xie DaWei. The differences of the blood routine indexes in patients with fatty liver and non-fatty liver[J]. Journal of Clinical Hepatology, 2010, 26(2): 163-166. |
[16] | Feng XiaoXia, Wang Lei, Xing LianJun, Liang HaiLin, Nie YuanXia. The function of dendritic cell in chronic hepatitis B patients with deficiency of kidney based on traditional chinese medicine syndrome differentiation intervention[J]. Journal of Clinical Hepatology, 2010, 26(6): 638-640. |
[18] | Chen MingWei, Yang MingGong, Wang YouMin, Wang ZhangJiang, Pan TianRong, Hu HongLin, Sun HaiYan. Risk factors analysis on nonalcoholic steatohepatitis in patients with type 2 diabetes[J]. Journal of Clinical Hepatology, 2004, 20(1): 44-45. |
[19] | Ding YanHua, He ShuMei, Wang XiaoWei, Xu MaoFeng, Niu JunQi. The clinical feature of 198 patients with fatty liver[J]. Journal of Clinical Hepatology, 2004, 20(5): 287-288. |